Skip to content
View all
Solutions
Integrated, end-to-end clinical development solutions designed to support every stage of your programme—from early research through to clinical delivery and data generation.
View all
Clinical Solutions
Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Drug Development Consulting
Strategic and scientific expertise to guide development, optimise trial design, and reduce risk.
View all
Human Challenge Solutions
World-leading human challenge models to generate early efficacy data and accelerate decision-making.
View all
Laboratory Solutions
Advanced laboratory services delivering high-quality data across bioanalysis, virology, and biomarkers.
View all
Integrated Solutions
A fully connected, end-to-end platform combining clinical, laboratory, recruitment, and consultancy expertise to deliver seamless, efficient clinical development.
View all
Biobank and Storage Solutions
hVIVO provides secure, HTA‑licensed cryostorage and biobanking services with multi‑temperature storage, 24/7 monitoring, full chain‑of‑custody management, and fast local access for biotech, pharma, and research partners.
View all
Clinical Pharmacology Early Phase
Phase I Units
Phase II/III
Data Management
Medical Monitoring
Medical Writing
Project Management
Quality Assurance
Recruitment
Regulatory Affairs
Clinical Trial Sites
Biostatistics
Clinical PK/PD Service
Statistics, study design, methodology
Clinical Pharmacology, PK/PD and Translational Modelling & Simulation
Chemistry, Manufacturing & Controls (CMC) Consulting
Non Clinical Development
Regulatory Affairs Consultancy
Due Diligence
Biosample Project management
Clinical Trials Legal Services
Medical Writing
Virus Production, Characterisation
Laboratory Services and Sample Analytics
Participant Screening & Recruitment for HCT
Human Challenge Unit & Clinical Delivery
RSV Model
Influenza Model
COVID-19 Model
HRV Model
hMPV model
Malaria Model
Asthma & COPD
Pre Clinical, PK/PD Studies
Assay Development & Validation
Scientific Consulting & Regulatory Support
Techniques, Technology & Automation
Clinical Trial Support & Kit Production
Bioanalysis & Characterisation
Biomarker Strategy & Identification
PBMC Processing & Isolation
Laboratory Accreditations
Microbiology Laboratory
Immunology Laboratory
Molecular Laboratory
Virology Laboratory
Virology Laboratory
Antiviral Drug Development
Sectors
Explore how we support pharma, biotech, CROs and start-ups across the clinical development lifecycle.
View all
Pharma
Partnering with global pharma to accelerate clinical development and deliver high-quality data.
View all
Biotech
Supporting biotech companies with flexible, expert-led solutions to advance innovative therapies.
View all
Start up
Helping start-ups navigate early development with strategic guidance and scalable clinical solutions.
View all
Working with Drug Development Investors
Our consulting team partners with investors to provide independent scientific, clinical, and regulatory insight across the full lifecycle of drug development — helping you assess risk, identify value, and support portfolio success.
View all
Therapeutics
Explore our therapeutic expertise across key disease areas, where our integrated clinical, laboratory, and consultancy capabilities support the development of innovative treatments from early research through to clinical proof-of-concept.
Cardiometabolic Solutions
Expertise in developing therapies for metabolic and cardiovascular conditions, supporting early-phase research through to clinical proof-of-concept.
View All
Dermatology Solutions
We are dedicated to delivering precise evaluations and compassionate care through specialized expertise, ensuring impactful outcomes in clinical trials and therapeutic development.
View all
Infectious Diseases Solutions
Global leadership in infectious disease research, with specialist models and expertise to accelerate vaccine and therapeutic development.
View all
Respiratory Solutions
Deep expertise in respiratory diseases, including asthma and viral infections, supported by advanced clinical and challenge capabilities.
View all
Renal & Hepatic Solutions
Focused support for kidney and liver disease programmes, combining clinical insight with specialist development and trial expertise.
View all
Women's Health Solutions
hVIVO is a specialist in women's health clinical studies, offering a broad spectrum of pharmacodynamic, endocrine, and reproductive assessments across conditions
View all
Insights
Access expert insights, upcoming events, and practical workshops from hVIVO, bringing together the latest thinking, research, and real-world expertise across the drug development spectrum, from leading scientific, medical and technical experts
View all
Upcoming Webinars & On Demand Education
Join hVIVO's expert-led webinars to explore the latest advances in clinical development, infectious disease, and human challenge models.
View all
Scientific Publications
Explore peer-reviewed scientific publications and clinical research papers supported by hVIVO’s scientific, medical, and operational research teams.
View all
Articles & Resources
Explore the latest insights, research, and expert analysis from hVIVO scientific, medical and technical leaders
View all
Conferences
Explore the in-person events we’re attending, including key conferences where our team will be exhibiting or visiting. Meet us on the ground, connect face-to-face, and discover how we’re engaging with the latest developments across our industry.
View all
Workshops
Participate in small, interactive workshops designed to provide hands-on insight and practical guidance across key areas of clinical development, led by hVIVO’s subject matter experts.
View all
News & Media
From expert interviews and video features to in-depth editorial contributions, this section brings together our presence in the titles that matter most to the biopharma community.
View all
On Demand | The future of cardiometabolic trials: From obesity to outcomes that matter
On Demand | Technical Due Diligence in Drug Development
On Demand | Accelerate Your hMPV Programme
On Demand | RSV Human Challenge Model
Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study
Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study
Prophylactic Efficacy of CD388, a Novel Drug–Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study
Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection
Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
Changes in memory and cognition during the SARS-CoV-2 human challenge study
SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections
Redesigning obesity trials for a chronic disease era
The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose
Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs
Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them
From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
SaxoCell Conference on Cell and Gene Therapy
11th German Pharm-Tox Summit 2026
BIO International Convention
World Vaccine Congress Europe
BIO-Europe 2026
Dutch Life Sciences Conference 2026
Workshop: Build Your Target Product Profile With Confidence
From Preclinical to Clinical: Essential Steps Toward First-In-Human Studies
Redesigning obesity trials for a chronic disease era
The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose
Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs
Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them
From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
Investors
hVIVO plc is listed on the London Stock Exchange AIM market (HVO). Find our results, share price, governance and shareholder information here.
Go to Investors
Results Centre
Financial results, annual reports, investor presentations and upcoming events
View Results Centre
Regulatory News
RNS announcements, press coverage and media resources from hVIVO
View Regulatory News
Corporate Governance
Board governance, ESG commitments, AIM Rule 26 disclosures and documents
View Corporate Governance
-
Solutions
Integrated, end-to-end clinical development solutions designed to support every stage of your programme—from early research through to clinical delivery and data generation.View all-
- Statistics, study design, methodology
- Clinical Pharmacology, PK/PD and Translational Modelling & Simulation
- Chemistry, Manufacturing & Controls (CMC) Consulting
- Non Clinical Development
- Regulatory Affairs Consultancy
- Due Diligence
- Biosample Project management
- Clinical Trials Legal Services
- Medical Writing
-
- Pre Clinical, PK/PD Studies
- Assay Development & Validation
- Scientific Consulting & Regulatory Support
- Techniques, Technology & Automation
- Clinical Trial Support & Kit Production
- Bioanalysis & Characterisation
- Biomarker Strategy & Identification
- PBMC Processing & Isolation
- Laboratory Accreditations
- Microbiology Laboratory
- Immunology Laboratory
- Molecular Laboratory
- Virology Laboratory
- Virology Laboratory
- Antiviral Drug Development
-
Sectors
Explore how we support pharma, biotech, CROs and start-ups across the clinical development lifecycle.View all -
Therapeutics
Explore our therapeutic expertise across key disease areas, where our integrated clinical, laboratory, and consultancy capabilities support the development of innovative treatments from early research through to clinical proof-of-concept. -
Insights
Access expert insights, upcoming events, and practical workshops from hVIVO, bringing together the latest thinking, research, and real-world expertise across the drug development spectrum, from leading scientific, medical and technical expertsView all-
- Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
- Safety, pharmacokinetics, and pharmacodynamics of sofnobrutinib, a novel non-covalent BTK inhibitor, in healthy subjects: First-in-human phase I study
- Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study
- Prophylactic Efficacy of CD388, a Novel Drug–Fc Conjugate, in a Human Influenza A/H3N2 Virus Challenge Model: A Randomized, Controlled Phase 2a Study
- Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine
- Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection
- Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
- Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine
- Changes in memory and cognition during the SARS-CoV-2 human challenge study
- SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infections
-
- Redesigning obesity trials for a chronic disease era
- The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose
- Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs
- Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
- What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them
- From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
-
- Redesigning obesity trials for a chronic disease era
- The Early‑Phase Anchor: Why Medical Monitoring Matters Long Before the First Dose
- Why Europe Is the Smartest Place to Start Early‑Phase Clinical Development for Early Stage/Emerging Biotechs
- Paper: Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults
- What Sponsors Get Wrong About Renal & Hepatic Studies — According to the People Running Them
- From RSV to hMPV: Building the Next Generation of Respiratory Challenge Models
-
Investors
hVIVO plc is listed on the London Stock Exchange AIM market (HVO). Find our results, share price, governance and shareholder information here.Go to Investors - About
- Participate
